Beach Crasher and Frosted Cherry Cookies: caryophyllene versus myrcene with the same THC range

How does Beach Crasher differ from Frosted Cherry Cookies if both have the same declared potency?

Leading compound and lineage. In the profile of Beach Crasher, caryophyllene takes the first place, while in the profile of Frosted Cherry Cookies, it is myrcene. The lineages of both cultivars do not converge in any common parent. However, the declared content of the active substance matches to the decimal, so the difference between them cannot be read from the packaging label.

The lineage of the first leads to two breeding lines, wedding crasher and tk bx1. The second was created from cherry cookie and reversed the white. None of these four names returns on the opposite side of the pair, and the pedigree graph of this comparison does not connect both varieties either through a common parent or a common grandparent. The common part of the name would not prove anything: the word frosted is carried by two cultivars here, and the second one, Frosted Lemon Angel, comes from lemon skunk and kosher kush, which is from a pair that has no point of contact with the lineage of the other side.

The third difference concerns how well documented both profiles are, and it is the most interesting one. The composition of Beach Crasher is described by two Polish industry services and they describe it differently: only one of them lists three compounds. The composition of Frosted Cherry Cookies is provided identically by both databases, which happens three times in this collection of 85 cultivars. This asymmetry returns later in the text, leading to a conclusion opposite to what intuition suggests.

What connects Beach Crasher and Frosted Cherry Cookies?

The same set of producers and a common part of the profile. Both varieties are supplied to Polish pharmacies by three entities: S-LAB, Synoptis Pharma, and Tilray. All five compounds listed with Frosted Cherry Cookies are also on the eight-element list of Beach Crasher, so the smaller profile is entirely contained within the larger one.

Three suppliers is a rare situation in this comparison. Out of 85 described cultivars, 64 have one producer in the register, eleven have two, and only ten have more than two. Beach Crasher and Frosted Cherry Cookies belong to this group of ten, and exactly the same trio of entities is associated with eight varieties from the entire collection. For the patient, this has practical consequences: the disappearance of one item from the pharmacy does not necessarily mean that the variety has fallen off the market.

They are also connected by what is missing in the data. For neither of them has the sibling field been filled out, although the lineage of both is established and supported by breeder material. An empty list is not a gap here: siblings arise when two cultivars share an identified parent, and the four lines recorded in the pedigrees of this pair do not appear with any other strain in the comparison. A broader description of each individually is on the strain page Beach Crasher oraz na stronie odmiany Frosted Cherry Cookies.

Why does the agreement of both sources regarding Frosted Cherry Cookies not determine which compound leads?

Because compliance concerns the list of names, not their order. Both databases list the same set of five compounds for this strain, and therefore the profile has a compliant status in the project, but neither places the same compound at the forefront. Compliance ends precisely at the listing.

BudCare reports for Frosted Cherry Cookies shares in which two compounds are at the top with identical values, so priority cannot be read from them at all; the data comparison tool then leaves the leading compound field empty instead of choosing the first one available. MedWeed does not provide shares, only order, and opens it with pinene. Myrcene, which the pharmacy catalog assigns as dominant for this strain, is only in second place at MedWeed. Among the ten cultivars used in fifteen comparisons of this dataset, this is the only profile with a compliant status.

For Beach Crasher, the arrangement is reversed. There, the sources differ in composition: bisabolol, limonene, and linalool are mentioned by only one of the two databases, the other does not recognize them for this strain, yet both consistently place caryophyllene in the first position. One strain thus has a certain listing and uncertain priority, while the other has an uncertain listing and certain priority. A label stating that one profile is compliant and the other contradictory does not resolve which of them is better understood.

We do not provide percentage shares for the names of the compounds at all, and this pair shows why. The four entries for Beach Crasher in the BudCare database sum up to 86, 86, 86, and 100 percent, with that hundred arising from four identical quarters, meaning it is rounded, not measured. The three entries for Frosted Cherry Cookies sum up to 79 percent each time. Since no one provides the total, the number assigned to a single compound does not indicate what part of anything it constitutes.

Why do we provide the THC content for both strains as a range, rather than as a single number?

Because under one trade name, several separate registration entries are hidden, and each declares its own potency. For both strains, the aggregate THC content range is 16.2-24.2%, but it does not come from the ranges of one manufacturer: it consists of declarations from several different entries from three entities.

The manufacturer's tolerance, which is ten percent of the declared value, cannot account for such a spread. This is evident from the registration names: Cannabis flos S-LAB, Cannabis flos Tilray, and Cannabis flos Synoptis Pharma appear for this pair in versions with different nominal values, with the lower end of the aggregate range coming from a weaker entry and the upper from a stronger one. The number entered in the registration name is therefore provided separately and always as a range, never as a ready measurement result of a specific package.

Registration entries appear and disappear, so comparing availability has a short shelf life. In the BudCare database, there are four entries for Beach Crasher, three for Frosted Cherry Cookies, and some of them are described as unavailable. The current status is provided by a comparison of strains available in pharmacies and it is this, not this text, that is the place for current data. A completely separate shelf is the category of dried flower with cannabidiol, sold over the counter: a different plant, a different dispensing method, and no common entry with pharmacies.

What has been shown in studies on caryophyllene, the leading compound of Beach Crasher?

Two preclinical studies, both on mice. The first described binding to the CB2 receptor and the abolition of the anti-inflammatory effect in animals lacking this receptor, while the second reduced pain response after oral administration. Neither concerned humans or inhalation of vapor from dried flower, so they do not directly transfer to this strain.

Gertsch and colleagues described in 2008 in the Proceedings of the National Academy of Sciences (PNAS), identifier PMID:18574142, that (E)-caryophyllene selectively bound to the CB2 receptor (Ki = 155 nM) and inhibited paw swelling induced by carrageenan in wild-type mice, but not in mice lacking the CB2 receptor (Cnr2-/-), indicating a CB2-dependent mechanism; the study did not include any anxiety tests. Study model: mouse (in vivo) and test tube (receptor binding, human cells).

Six years later, the Klauke team approached the same receptor from the pain side, in European Neuropsychopharmacology, identifier PMID:24210682. Oral caryophyllene reduced the late inflammatory phase of pain in the formalin test in a CB2 receptor-dependent manner, with no effect on the early phase; in a neuropathic pain model, it alleviated thermal hyperalgesia and mechanical allodynia without developing tolerance with chronic administration. Study model: rodent (mouse).

In neither of the two studies was caryophyllene tested on humans or in inhaled form from dried flower; both works concern oral or systemic administration in mouse models of pain and inflammation, not sleep or mood. For the comparative side, this means that the advantage of caryophyllene in the Beach Crasher profile is a fact about the raw material composition, not a promise of any action in the patient.

What has been shown in studies on myrcene and why do the results not align in one direction?

Three studies on mice, with conclusions diverging in different directions. Intraperitoneal injection prolonged sleep while simultaneously presenting a slightly anxiogenic picture, inhalation of vapor acted anxiolytically in females, and a separate study described the abolition of pain response blocked by naloxone. The direction depends on the route of administration and the sex of the animal.

The Vale team studied sleep and anxiety behavior in 2002, and published the results in Phytomedicine under identifier PMID:12587690. Myrcene administered intraperitoneally (100-200 mg/kg) reduced the locomotor activity of mice in the open field test, prolonged sleep time induced by pentobarbital (by about 2.6 times at 200 mg/kg), and reduced the number of entries into the open arms of the elevated plus maze, which the authors described as a weak anxiogenic effect, not anxiolytic. Study model: rodent (mouse, intraperitoneal administration).

An earlier work by the Rao team from 1990, published in the Journal of Pharmacy and Pharmacology, identifier PMID:1983154, concerned pain. Myrcene (10-40 mg/kg) reduced pain responses in mice in hot plate and writhing tests induced by acetic acid; the effect was abolished by naloxone and yohimbine, indicating the involvement of alpha2-adrenergic receptors and the release of endogenous opioids. Study model: rodent (mouse).

The latest of the three, Wagner and colleagues, appeared in 2024 in NeuroSci under identifier PMID:39728677. With short puffs of vapor, mimicking inhalation in humans, beta-myrcene acted anxiolytically in the elevated plus maze in female mice, and in males only with a single puff. Unlike linalool, myrcene did not produce a synergistic effect with cannabidiol in either sex. Study model: rodent (mouse, vapor puffs).

In humans, myrcene alone has not been shown to alleviate insomnia at doses typical for inhalation of dried flower. The direction of the effect in rodents depends on the route of administration and sex: intraperitoneal injection in 2002 described a slightly anxiogenic effect, while inhalation in 2024 showed an anxiolytic effect in females. These two results do not negate each other; they simply show that the conclusion depends on conditions that no popular strain database provides.

How long does the effect last and does the strain influence this?

The influence is significantly smaller than the route of administration. Neither for Beach Crasher nor for Frosted Cherry Cookies has a pharmacokinetic study been published, so the course is described for the method of intake, not for the cultivar. The following ranges come from the description of absorption physiology and are the same for both strains.

The route of administration determines the course more than the variety itself. After vaporization, the substance passes from the lungs to the blood almost immediately, so the first sensations appear after a few minutes, the intensity increases for another ten to thirty minutes, and the whole effect lasts for two to four hours. After ingestion, the raw material first passes through the intestine and liver, so the first sensations are awaited from half an hour to two hours, and the episode can last six, sometimes eight hours. Hence the most common mistake with oral administration: anyone who thinks nothing is happening after thirty minutes and takes another dose will receive both doses at once. The above ranges describe the route of administration, not this variety; pharmacokinetic studies for a single cultivar have not been published.

For the comparison of this pair, the outcome is simple. The difference between the caryophyllene-based profile and the myrcene-based profile does not translate into a different duration of the episode, as the method of intake determines it. No separate duration comparisons for Beach Crasher and Frosted Cherry Cookies are published by either of the two services from which these profiles originate.

What side effects have been reported for each of these two strains?

Separately, nothing has been reported for either of them, as the reporting system does not operate on strain names. The registry links the event to the medicinal product and batch number, so the question of which of these two is better tolerated finds no answer in the available data.

Reports of adverse effects are collected for medicinal products with a batch number, not for the strain name, so the following pertains to hemp dried flower as a group of raw materials. The most frequently reported symptoms are dry mouth, red eyes, and increased heart rate. Dizziness upon rapid standing, daytime drowsiness, and temporary worsening of short-term memory are less frequently described, as well as anxiety that increases with dosage. A separate issue is medications taken concurrently, especially sedatives and those affecting coagulation: their assessment requires knowledge of the entire list of preparations, not just the description of the plant. We do not provide the frequency of these symptoms numerically, as public compilations for hemp dried flower in Poland do not separate them by individual products.

The varying number of registered entries does not resolve anything here. Beach Crasher has four entries in the pharmacy catalog, Frosted Cherry Cookies has three, and a larger number indicates a broader supply, not higher or lower risk. Comparing the number of submissions between the two strains would be akin to comparing sales volumes, not the safety of the raw material.

Frequently Asked Questions about both strains

Are Beach Crasher and Frosted Cherry Cookies related?

Not in the sense understood by pedigree charts. The first comes from wedding crasher and tk bx1, the second from cherry cookie and reversed the white, and none of these four lines returns on the opposite side. Both have an empty sibling field, although the pedigree of both is established.

Which of these two strains is stronger?

None, if looking at the manufacturer's declaration. Both have the same THC content range in the register, 16.2-24.2%, composed of declarations from several individual entries with varying nominal strength. A single package may therefore be weaker or stronger than another package of the same strain.

Why don't you provide percentage shares for the aromatic ingredients?

Because the denominator is unknown. The four entries for Beach Crasher sum up in the BudCare database to 86 or 100 percent, while the three entries for Frosted Cherry Cookies always total 79 percent, with that hundred coming from four identical quarters. A number without a known whole does not indicate what part of anything it describes.

What does it mean that the profile of one strain is consistent, while the other is contradictory?

It simply means that for Frosted Cherry Cookies both services list the same set of names, while for Beach Crasher the lists diverge. Consistency of the listing does not imply agreement on precedence, and with Frosted Cherry Cookies, that is exactly the case: none of the sources determines which ingredient leads.

Does either of them last longer?

Nothing suggests that. The duration of the episode depends on the route of administration, and pharmacokinetic studies for a single cultivar have not been published for either Beach Crasher or Frosted Cherry Cookies. Therefore, comparing the duration of effects between these two strains has no basis in data.

Can the dried flower from these strains be purchased without a prescription?

No. Both strains are raw materials dispensed exclusively by prescription, in the Rpw category, and the justification for their use is determined by the attending physician. Dried flower from industrial hemp with cannabidiol, available without a prescription, comes from a different plant and is on a completely different shelf.

Dried hemp is a pharmaceutical raw material dispensed by prescription in the Rpw category. The material is informational in nature and does not replace consultation with the attending physician. Editorial text: redakcja ubucha.pl.